The science is advancing quickly
Steve Gao, MD, PhD, and colleagues at Gilead Sciences conducted two studies investigating trends in GLP-1 use among patients with MASH and compensated cirrhosis
The decrease in mean GFR at 52 weeks was smaller in the high (1.5 mg) and low dose dulaglutide (0.75 mg) treatment groups (both 0.7 ml/min/1.73 m2) vs
For guidance on oral liquid dosing schedules during travel, maintain the same timing you use at home
The right path depends on individual circumstances including timeline urgency, financial resources, comfort with self-management, and personal risk tolerance
PlexusDx offers compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan and can help describe the pathway-level variants involved